Evaluation of the Merits and Limitations of Evidence-Based Medicine.
Publication
, Journal Article
O'Connor, DM; Nathan, NR; Kroshinsky, D
Published in: JAMA Dermatol
August 1, 2020
Duke Scholars
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
August 1, 2020
Volume
156
Issue
8
Start / End Page
925
Location
United States
Related Subject Headings
- Medical Overuse
- Humans
- Evidence-Based Medicine
- Dermatology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
O’Connor, D. M., Nathan, N. R., & Kroshinsky, D. (2020). Evaluation of the Merits and Limitations of Evidence-Based Medicine. JAMA Dermatol, 156(8), 925. https://doi.org/10.1001/jamadermatol.2020.1943
O’Connor, Daniel M., Neera R. Nathan, and Daniela Kroshinsky. “Evaluation of the Merits and Limitations of Evidence-Based Medicine.” JAMA Dermatol 156, no. 8 (August 1, 2020): 925. https://doi.org/10.1001/jamadermatol.2020.1943.
O’Connor DM, Nathan NR, Kroshinsky D. Evaluation of the Merits and Limitations of Evidence-Based Medicine. JAMA Dermatol. 2020 Aug 1;156(8):925.
O’Connor, Daniel M., et al. “Evaluation of the Merits and Limitations of Evidence-Based Medicine.” JAMA Dermatol, vol. 156, no. 8, Aug. 2020, p. 925. Pubmed, doi:10.1001/jamadermatol.2020.1943.
O’Connor DM, Nathan NR, Kroshinsky D. Evaluation of the Merits and Limitations of Evidence-Based Medicine. JAMA Dermatol. 2020 Aug 1;156(8):925.
Published In
JAMA Dermatol
DOI
EISSN
2168-6084
Publication Date
August 1, 2020
Volume
156
Issue
8
Start / End Page
925
Location
United States
Related Subject Headings
- Medical Overuse
- Humans
- Evidence-Based Medicine
- Dermatology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences